Nociceptin/orphanin FQ peptide in hypothalamic neurones associated with the control of feeding behaviour

Journal of Neuroendocrinology

Volumn 22, Issue 2, 2010, Pages 75-82

  Maolood, N ^a   Meister, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AGRP; Dynorphin; MCH; Orexin; POMC; TRH

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; COLCHICINE; CORTICOTROPIN RELEASING FACTOR; DYNORPHIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE Y; NOCICEPTIN; OREXIN; PROOPIOMELANOCORTIN; PROTIRELIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; BRAIN REGION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEEDING BEHAVIOR; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; THALAMUS MIDLINE NUCLEUS;

ALPHA-MSH; ANIMALS; ARCUATE NUCLEUS; FEEDING BEHAVIOR; HYPOTHALAMIC AREA, LATERAL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEURONS; NEUROPEPTIDES; OPIOID PEPTIDES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 75449101018     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2009.01946.x     Document Type: Article

References (48)

1. Lambert DG. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 2008, 8:694-710.
2. Mazarguil H, Vassart G, Parmentier M, Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 6549:532-535.
3. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 7:792-794.
4. Houtani T, Nishi M, Takeshima H, Sato K, Sakuma S, Kakimoto S, Ueyama T, Noda T, Sugimoto T. Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice. J Comp Neurol 2000, 3:489-508.
5. Bryant W, Janik J, Baumann M, Callahan P. Orphanin FQ stimulates prolactin and growth hormone release in male and female rats. Brain Res 1998, 2:228-233.
6. Jenck F, Moreau JL, Martin JR, Kilpatrick GJ, Reinscheid RK, Monsma FJ, Nothacker HP, Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA 1997, 26:14854-14858.
7. Xu XJ, Hao JX, Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 1996, 13:2092-2094.
8. Sinchak K, Hendricks DG, Baroudi R, Micevych PE. Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. Neuroreport 1997, 18:3857-3860.
9. Sandin J, Georgieva J, Schött PA, Ögren SO, Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci 1997, 1:194-197.
10. Mamiya T, Yamada K, Miyamoto Y, König N, Watanabe Y, Noda Y, Nabeshima T. Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-d-aspartate receptors. Mol Psychiatry 2003, 8:752-765.
11. Di Giannuario A, Pieretti S. Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats. Peptides 2000, 7:1125-1130.
12. Devine DP, Taylor L, Reinscheid RK, Monsma FJ, Civelli O, Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 1996, 11:1387-1396.
13. Pomonis JD, Billington CJ, Levine AS. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport 1996, 1:369-371.
14. Polidori C, de Caro G, Massi M. The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides 2000, 7:1051-1062.
15. Nicholson JR, Akil H, Watson SJ. Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors. Neuroscience 2002, 2:637-643.
16. Olszewski PK, Billington CJ, Levine AS. Fos expression in feeding-related brain areas following intracerebroventricular administration of orphanin FQ in rats. Brain Res 2000, 1:171-175.
17. Stratford TR, Holahan MR, Kelley AE. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport 1997, 2:423-426.
18. Mollereau C, Simons MJ, Soularue P, Liners F, Vassart G, Meunier JC, Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 1996, 16:8666-8670.
19. Neal CR, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 1999, 4:503-547.
20. Leibowitz SF. Hypothalamic neuropeptide Y in relation to energy balance. Ann NY Acad Sci 1990, 611:284-301.
21. Flier JS, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998, 4:437-440.
22. Leventhal L, Mathis JP, Rossi GC, Pasternak GW, Bodnar RJ. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur J Pharmacol 1998, 1:R1-R3.
23. Matsushita H, Ishihara A, Mashiko S, Tanaka T, Kanno T, Iwaasa H, Ohta H, Kanatani A. Chronic intracerebroventricular infusion of nociceptin/orphanin FQ produces body weight gain by affecting both feeding and energy metabolism in mice. Endocrinology 2009, 5:2668-2673.
24. Meister B. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiol Behav 2007, 1-2:263-271.
25. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
26. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8:571-578.
27. Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ. Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 2003, 4:837-845.
28. Foradori CD, Amstalden M, Coolen LM, Singh SR, McManus CJ, Handa RJ, Goodman RL, Lehman MN. Orphanin FQ: evidence for a role in the control of the reproductive neuroendocrine system. Endocrinology 2007, 148:4993-5001.
29. Meister B, Gömüç B, Suarez E, Ishii Y, Dürr K, Gillberg L. Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype. Eur J Neurosci 2006, 24:2731-2740.
30. Fekete C, Légrádi G, Mihály E, Huang QH, Tatro JB, Rand WM, Emerson CH, Lechan RM. α-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 2000, 20:1550-1558.
31. Markey KA, Kondo H, Shenkman L, Goldstein M. Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 1980, 17:79-85.
32. Klootwijk W, Vaessen LM, Bernard BF, Rondeel JM, De Greef WJ, Visser TJ. Production and characterization of monoclonal and polyclonal antibodies against thyrotropin-releasing hormone. Hybridoma 1995, 14:285-290.
33. Gardell LR, Wang R, Ehrenfels C, Ossipov MH, Rossimando AJ, Miller S, Buckley C, Cai AK, Tse A, Foley SF, Gong B, Walua L, Carmillo P, Worley D, Huang C, Engbeer T, Pepinsky B, Cate RL, Vanderah TW, Lai J, Sah DWY, Porreca F. Multiple actions of systemic artemin in experimental neuropathy. Nature Med 2003, 9:1383-1389.
34. Meister B, Hökfelt T, Steinbusch HW, Skagerberg G, Lindvall O, Geffard M, Joh TH, Cuello AC, Goldstein M. Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-dopa? J Chem Neuroanat 1988, 1:59-64.
35. Kim HW, Kwon YB, Ham TW, Roh DH, Yoon SY, Han HJ, Kim KW, Lee WS, Kim JK, Yoon OB, Lee JH. Distribution of nociceptin-like immunoreactivity in the central nervous system of the Mongolian gerbil: an immunohistochemical study. Anat Histol Embryol 2002, 3:187-192.
36. Bewick GA, Dhillo WS, Darch SJ, Murphy KG, Gardiner JV, Jethwa PH, Kong WM, Ghatei MA, Bloom SR. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) and agouti-related protein (AgRP) neurons coexpress the NOP1 receptor and nociceptin alters CART and AgRP release. Endocrinology 2005, 8:3526-3534.
37. Hahn TM, Breininger JF, Baskin DG, Schwartz MW. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1998, 1:271-272.
38. Broberger C, Johansen J, Johansson C, Schalling M, Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998, 25:15043-15048.
39. Chen P, Li C, Haskell-Luevano C, Cone RD, Smith MS. Altered expression of agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation. Endocrinology 1999, 6:2645-2650.
40. Bungo T, Shiraishi J, Yanagita K, Ohta Y, Fujita M. Effect of nociceptin/orphanin FQ on feeding behavior and hypothalamic neuropeptide expression in layer-type chicks. Gen Comp Endocrinol 2009, 2:47-51.
41. Chesterfield M, Janik J, Murphree E, Lynn C, Schmidt E, Callahan P. Orphanin FQ/nociceptin is a physiological regulator of prolactin secretion in female rats. Endocrinology 2006, 147:5087-5093.
42. Maolood N, Meister B. Dynorphin in pro-opiomelanocortin neurons of the hypothalamic arcuate nucleus. Neuroscience 2008, 154:1121-1131.
43. Mitsuma T, Hirooka Y, Mori Y, Kayama M, Adachi K, Rhue N, Ping J, Ikai R, Nakayashiki A, Nogimori T. Nociceptin stimulates thyrotropin secretion in rats. Horm Res 1999, 3:140-144.
44. Elmquist JK. CNS regulation of energy balance and body weight: insights from rodent models. Lab Anim Sci 1998, 6:630-637.
45. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 4:573-585.
46. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, Bloom SR. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 1997, 1:351-355.
47. Morley JE, Levine AS. Involvement of dynorphin and the kappa opioid receptor in feeding. Peptides 1983, 6:797-800.
48. Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, Willie JT, Beuckmann CT, Chemelli RM, Sakurai T, Yanagisawa M, Saper CB, Scammell TE. Orexin (hypocretin) neurons contain dynorphin. J Neurosci 2001, 19:1-6. RC168